Condition (MeSH)
Spherocytosis, Hereditary
ClinicalTrials.gov lists 7 trials for Spherocytosis, Hereditary or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Spherocytosis, Hereditary itself; the rest are tagged with a narrower condition beneath it.
When did Spherocytosis, Hereditary trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2020 | 3 |
| 2016 | 1 |
| 2010 | 1 |
| 2009 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Spherocytosis, Hereditary trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 2 |
| Observational | 5 |
How many Spherocytosis, Hereditary trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Completed | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Spherocytosis, Hereditary? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy. | British journal of haematology | 2024 | Yes |
| Oxidative stress contributes to hemolysis in patients with hereditary spherocytosis and can be ameliorated by fermented papaya preparation. | Annals of hematology | 2011 | Yes |
| Splenectomy for hereditary spherocytosis: complete, partial or not at all? | Expert review of hematology | 2011 | Yes |
| Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. | Cytometry. Part B, Clinical cytometry | 2008 | Yes |
| Laparoscopic splenectomy using the harmonic scalpel. | Journal of laparoendoscopic surgery | 1996 | Yes |
Showing 5 of 10 publications.
Prevalence (9)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Hereditary spherocytosis | Prevalence at birth | 1-5 / 10 000 | United States | US | Exact |
| Hereditary spherocytosis | Prevalence at birth | 1-5 / 10 000 | United States | US | Exact |
| Hereditary spherocytosis | Prevalence at birth | 1-5 / 10 000 | United States | US | Unspecified |
| Hereditary spherocytosis | Point prevalence | 1-5 / 10 000 | Germany | Not stated | Unspecified |
| Hereditary spherocytosis | Point prevalence | 1-5 / 10 000 | Europe | Not stated | Unspecified |
Showing 5 of 9 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Hereditary spherocytosis | 822 | Exact | Orphadata Science knowledge files, Product 1 |
| Hereditary spherocytosis | 822 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.